RARA CRAFT DATABASE for FDA Medical Devices
PMAP160033

FDA DEVICE FACTS

Powerheart® G5 AED, Powerheart® AED G3 Plus, and Powerheart® AED G3

ZOLL Medical Corporation

Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。

DECISION DATEDecember 7, 2018PRODUCT CODEMKJ

Indications for use

The Powerheart® AED G3 is indicated for emergency treatment of victims exhibiting symptoms of sudden cardiac arrest who are:

• unresponsive,

• not breathing normally, and

• without pulse.

When the patient is a child or infant up to 8 years of age, or up to 55 lbs. (25kg), the device should be used with the Intellisense™ Defibrillation Pad – Pediatric. The therapy should not be delayed to determine the patient's exact age or weight.

The Powerheart® AED G3 is intended to be used by personnel who have been trained in its operation.

The Powerheart® AED G3 Plus is indicated for emergency treatment of victims exhibiting symptoms of sudden cardiac arrest who are:

• unresponsive,

• not breathing normally, and

• without pulse.

When the patient is a child or infant up to 8 years of age, or up to 55 lbs. (25kg), the device should be used with the Intellisense™ Defibrillation Pad – Pediatric. The therapy should not be delayed to determine the patient's exact age or weight.

The Powerheart® AED G3 Plus is intended to be used by personnel who have been trained in its operation.

The Powerheart® AED G5 is indicated for emergency treatment of victims exhibiting symptoms of sudden cardiac arrest who are:

• unresponsive,

• not breathing normally, and

• without pulse.

When a patient is a child up to 8 years of age, or up to 25kg (55 lbs.), the AED should be used with the Intellisense™ Defibrillation Pad – Pediatric. The therapy should not be delayed to determine the patient's exact age or weight.

The G5 Automated External Defibrillator (AED) is intended to be used by persons who have been trained in its operation.

When used with the optional Intellisense™ Defibrillation Pad – ICPR, the device offers CPR performance feedback to aid a trained rescuer by providing compression rate and depth performance feedback through audio prompting. The Intellisense™ Defibrillation Pad – ICPR is indicated-for use on cardiac arrest patients 8 years of age or older, or who weigh more than 25 kg (55 lbs.).

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 2, 2026